Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.218 EUR | +0.33% | +2.35% | -5.43% |
07-01 | Abionyx Pharma: successful capital increase | CF |
06-14 | Abionyx: positive response from FDA, share price rises | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.43% | 42.24M | |
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- ABNX Stock
- News ABIONYX Pharma
- Cerenis Therapeutics Holding SA Announces Consolidated Earnings Results for the Year Ended December 31, 2018